Bold (Business Opportunities for L'Oréal Development)L'Oréal's venture capital fund, has announced a minority investment in Debut, becoming the only player in the beauty industry to invest in this company. The investment will enable Debut - a US biotech - to rapidly scale up its manufacturing platform and meet the growing demand for innovative ingredients for use in cosmetics, skincare and packaging.
This investment builds on L'Oréal and Debut's joint development programs, leveraging Debut's intellectual property portfolio of over 7,000 ingredients to bring high-value, longer-lasting ingredients to market faster.
Based in San Diego, California, Debut specializes in the discovery, formulation, clinical testing and manufacturing of innovative ingredients and products, from start to finish. Its advanced biomanufacturing platform, based on a cell-free approach, bypasses the limitations of traditional fermentation and takes direct control of biological processes to manufacture complex natural products, such as high-performance polyphenols, biopolymers and natural colorants, valued for their anti-aging antioxidant properties.
This type of synthetic biology considerably reduces manufacturing complexity and increases the quantity of product that can be obtained. Using this platform, new ingredients can be delivered in just six weeks - from discovery to pre-production - and used in a multitude of better-performing, longer-lasting beauty products; from moisturizers to serums to hair care.
"Debut responds to one of the fundamental challenges of the beauty world: stimulating innovation without the intensive use of resources and environmental impact associated with dependence on traditional means of production, said Barbara Lavernos, Executive Vice President, Research, Innovation and Technology at L'Oréal. Cell-free bio-production is not science fiction: we're there. What could be more exciting than to be the only beauty player to invest in these technologies with Debut? We're delighted to be associated with this leading biotech and, together, we want to create remarkable active beauty innovations, while protecting the planet's resources."
"We are absolutely delighted to have L'Oréal as an investor, at a time when advanced science is needed to fundamentally reinvent the way beauty ingredients are made, and to meet the challenges of cost, quality, scalability and sustainability. said Dr. Joshua Britton, Managing Director of Debut. Debut's ambition is to disrupt the active ingredient manufacturing process and, in so doing, help industry leaders like L'Oréal maintain their innovative edge and desirability, while fulfilling their responsibility to the planet and its consumers."
